世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
世界および米国の非侵襲的非経口的スクリーニング機器市場の洞察、2027年までの予測Global and United States Non-invasive Parenteral Screening Instruments Market Insights, Forecast to 2027 非侵襲的非経口的スクリーニングは、母親の血清中に存在する胎児の細胞遊離DNAを検査し、一般的な胎児の異数性を検出する新しい遺伝学的プロセスである。その主な目的は、トリソミー21（ダウン症候群）、トリソミ... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー非侵襲的非経口的スクリーニングは、母親の血清中に存在する胎児の細胞遊離DNAを検査し、一般的な胎児の異数性を検出する新しい遺伝学的プロセスである。その主な目的は、トリソミー21（ダウン症候群）、トリソミー18（エドワード症候群）、トリソミー13（パタウ症候群）、モノソミーX（ターナー症候群）などの遺伝性疾患の早期発見です。また、胎児の血液型やアカゲザルを検出することもできます。現在、世界市場で販売されているNIPTの中には、MaterniT21 PLUS、Harmony、Panorama、NIFTY、PrenaTest、BambniTestなどの製品があります。市場分析と洞察。世界および米国の非侵襲的非経口的スクリーニング機器市場 当レポートでは、世界および米国の非侵襲的非経口スクリーニング機器市場に焦点を当てています。 2020年の非侵襲性非経口スクリーニング機器の世界市場規模はXX百万米ドルで、2021年から2027年の間にXX％のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。米国では、非侵襲的非経口スクリーニング機器の市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予測されています。 世界の非侵襲的非経口スクリーニング装置の範囲と市場規模 非侵襲的非経口スクリーニング機器市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されます。世界の非侵襲的非経口的スクリーニング機器市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域（国）別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。 米国市場では、2016-2027年の非侵襲的非経口スクリーニング機器の市場規模を、プレイヤー別、タイプ別、アプリケーション別に分析しています。主要なプレイヤーには、アメリカ合衆国で重要な役割を果たす世界的なプレイヤーや地域のプレイヤーが含まれます。 タイプ別セグメント 超音波診断装置 次世代シークエンス装置 ポリメラーゼ連鎖反応装置 マイクロアレイ その他 用途別セグメント 診断機関 病院 地域別 北アメリカ U.S. カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア アジアパシフィック 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中近東・アフリカ トルコ サウジアラビア U.A.E. 会社別 GEヘルスケア フィリップス イルミナ サーモフィッシャーサイエンティフィック ロシュ パックバイオ パーキネルマー チーゲン アジレント・テクノロジー BGIグループ 目次1 Study Coverage1.1 Non-invasive Parenteral Screening Instruments Product Introduction 1.2 Market by Type 1.2.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type 1.2.2 Ultrasound Devices 1.2.3 Next-Generation Sequencing Systems 1.2.4 Polymerase Chain Reaction Instruments 1.2.5 Microarrays 1.2.6 Others 1.3 Market by Application 1.3.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Application 1.3.2 Diagnostic Laboratories 1.3.3 Hospitals 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Non-invasive Parenteral Screening Instruments Market Size, Estimates and Forecasts 2.1.1 Global Non-invasive Parenteral Screening Instruments Revenue 2016-2027 2.1.2 Global Non-invasive Parenteral Screening Instruments Sales 2016-2027 2.2 Global Non-invasive Parenteral Screening Instruments, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Non-invasive Parenteral Screening Instruments Historical Market Size by Region (2016-2021) 2.3.1 Global Non-invasive Parenteral Screening Instruments Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Non-invasive Parenteral Screening Instruments Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Non-invasive Parenteral Screening Instruments Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Region (2022-2027) 2.4.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Region (2022-2027) 3 Global Non-invasive Parenteral Screening Instruments Competitor Landscape by Players 3.1 Global Top Non-invasive Parenteral Screening Instruments Manufacturers by Sales 3.1.1 Global Non-invasive Parenteral Screening Instruments Sales by Manufacturer (2016-2021) 3.1.2 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Non-invasive Parenteral Screening Instruments Manufacturers by Revenue 3.2.1 Key Non-invasive Parenteral Screening Instruments Manufacturers Covered: Ranking by Revenue 3.2.2 Global Non-invasive Parenteral Screening Instruments Revenue by Manufacturers (2016-2021) 3.2.3 Global Non-invasive Parenteral Screening Instruments Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Non-invasive Parenteral Screening Instruments Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Instruments Revenue in 2020 3.2.6 Global Non-invasive Parenteral Screening Instruments Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Non-invasive Parenteral Screening Instruments Price by Manufacturers 3.4 Global Non-invasive Parenteral Screening Instruments Manufacturing Base Distribution, Product Types 3.4.1 Non-invasive Parenteral Screening Instruments Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Non-invasive Parenteral Screening Instruments Product Type 3.4.3 Date of International Manufacturers Enter into Non-invasive Parenteral Screening Instruments Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Non-invasive Parenteral Screening Instruments Market Size by Type (2016-2021) 4.1.1 Global Non-invasive Parenteral Screening Instruments Sales by Type (2016-2021) 4.1.2 Global Non-invasive Parenteral Screening Instruments Revenue by Type (2016-2021) 4.1.3 Non-invasive Parenteral Screening Instruments Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Type (2022-2027) 4.2.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Type (2022-2027) 4.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Type (2022-2027) 4.2.3 Non-invasive Parenteral Screening Instruments Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Non-invasive Parenteral Screening Instruments Market Size by Application (2016-2021) 5.1.1 Global Non-invasive Parenteral Screening Instruments Sales by Application (2016-2021) 5.1.2 Global Non-invasive Parenteral Screening Instruments Revenue by Application (2016-2021) 5.1.3 Non-invasive Parenteral Screening Instruments Price by Application (2016-2021) 5.2 Non-invasive Parenteral Screening Instruments Market Size Forecast by Application (2022-2027) 5.2.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Application (2022-2027) 5.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Application (2022-2027) 5.2.3 Global Non-invasive Parenteral Screening Instruments Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 6.1.1 United States Non-invasive Parenteral Screening Instruments Sales YoY Growth 2016-2027 6.1.2 United States Non-invasive Parenteral Screening Instruments Revenue YoY Growth 2016-2027 6.1.3 United States Non-invasive Parenteral Screening Instruments Market Share in Global Market 2016-2027 6.2 United States Non-invasive Parenteral Screening Instruments Market Size by Players (International and Local Players) 6.2.1 United States Top Non-invasive Parenteral Screening Instruments Players by Sales (2016-2021) 6.2.2 United States Top Non-invasive Parenteral Screening Instruments Players by Revenue (2016-2021) 6.3 United States Non-invasive Parenteral Screening Instruments Historic Market Review by Type (2016-2021) 6.3.1 United States Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2016-2021) 6.3.2 United States Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2016-2021) 6.3.3 United States Non-invasive Parenteral Screening Instruments Price by Type (2016-2021) 6.4 United States Non-invasive Parenteral Screening Instruments Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Non-invasive Parenteral Screening Instruments Sales Forecast by Type (2022-2027) 6.4.2 United States Non-invasive Parenteral Screening Instruments Revenue Forecast by Type (2022-2027) 6.4.3 United States Non-invasive Parenteral Screening Instruments Price Forecast by Type (2022-2027) 6.5 United States Non-invasive Parenteral Screening Instruments Historic Market Review by Application (2016-2021) 6.5.1 United States Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2016-2021) 6.5.2 United States Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2016-2021) 6.5.3 United States Non-invasive Parenteral Screening Instruments Price by Application (2016-2021) 6.6 United States Non-invasive Parenteral Screening Instruments Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Non-invasive Parenteral Screening Instruments Sales Forecast by Application (2022-2027) 6.6.2 United States Non-invasive Parenteral Screening Instruments Revenue Forecast by Application (2022-2027) 6.6.3 United States Non-invasive Parenteral Screening Instruments Price Forecast by Application (2022-2027) 7 North America 7.1 North America Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 7.2 North America Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country 7.2.1 North America Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021) 7.2.2 North America Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 8.2 Asia Pacific Non-invasive Parenteral Screening Instruments Market Facts & Figures by Region 8.2.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region (2016-2021) 8.2.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 9.2 Europe Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country 9.2.1 Europe Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021) 9.2.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 10.2 Latin America Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country 10.2.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021) 10.2.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country 11.2.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021) 11.2.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 GE Healthcare 12.1.1 GE Healthcare Corporation Information 12.1.2 GE Healthcare Description and Business Overview 12.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GE Healthcare Non-invasive Parenteral Screening Instruments Products Offered 12.1.5 GE Healthcare Recent Development 12.2 Philips 12.2.1 Philips Corporation Information 12.2.2 Philips Description and Business Overview 12.2.3 Philips Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Philips Non-invasive Parenteral Screening Instruments Products Offered 12.2.5 Philips Recent Development 12.3 Illumina 12.3.1 Illumina Corporation Information 12.3.2 Illumina Description and Business Overview 12.3.3 Illumina Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Illumina Non-invasive Parenteral Screening Instruments Products Offered 12.3.5 Illumina Recent Development 12.4 Thermo Fisher Scientific 12.4.1 Thermo Fisher Scientific Corporation Information 12.4.2 Thermo Fisher Scientific Description and Business Overview 12.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Products Offered 12.4.5 Thermo Fisher Scientific Recent Development 12.5 Roche 12.5.1 Roche Corporation Information 12.5.2 Roche Description and Business Overview 12.5.3 Roche Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Roche Non-invasive Parenteral Screening Instruments Products Offered 12.5.5 Roche Recent Development 12.6 PacBio 12.6.1 PacBio Corporation Information 12.6.2 PacBio Description and Business Overview 12.6.3 PacBio Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.6.4 PacBio Non-invasive Parenteral Screening Instruments Products Offered 12.6.5 PacBio Recent Development 12.7 Perkinelmer 12.7.1 Perkinelmer Corporation Information 12.7.2 Perkinelmer Description and Business Overview 12.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Perkinelmer Non-invasive Parenteral Screening Instruments Products Offered 12.7.5 Perkinelmer Recent Development 12.8 Qiagen 12.8.1 Qiagen Corporation Information 12.8.2 Qiagen Description and Business Overview 12.8.3 Qiagen Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Qiagen Non-invasive Parenteral Screening Instruments Products Offered 12.8.5 Qiagen Recent Development 12.9 Agilent Technologies 12.9.1 Agilent Technologies Corporation Information 12.9.2 Agilent Technologies Description and Business Overview 12.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Agilent Technologies Non-invasive Parenteral Screening Instruments Products Offered 12.9.5 Agilent Technologies Recent Development 12.10 BGI Group 12.10.1 BGI Group Corporation Information 12.10.2 BGI Group Description and Business Overview 12.10.3 BGI Group Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.10.4 BGI Group Non-invasive Parenteral Screening Instruments Products Offered 12.10.5 BGI Group Recent Development 12.11 GE Healthcare 12.11.1 GE Healthcare Corporation Information 12.11.2 GE Healthcare Description and Business Overview 12.11.3 GE Healthcare Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.11.4 GE Healthcare Non-invasive Parenteral Screening Instruments Products Offered 12.11.5 GE Healthcare Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Non-invasive Parenteral Screening Instruments Industry Trends 13.2 Non-invasive Parenteral Screening Instruments Market Drivers 13.3 Non-invasive Parenteral Screening Instruments Market Challenges 13.4 Non-invasive Parenteral Screening Instruments Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Non-invasive Parenteral Screening Instruments Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
SummaryNon-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others. Table of Contents1 Study Coverage1.1 Non-invasive Parenteral Screening Instruments Product Introduction 1.2 Market by Type 1.2.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type 1.2.2 Ultrasound Devices 1.2.3 Next-Generation Sequencing Systems 1.2.4 Polymerase Chain Reaction Instruments 1.2.5 Microarrays 1.2.6 Others 1.3 Market by Application 1.3.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Application 1.3.2 Diagnostic Laboratories 1.3.3 Hospitals 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Non-invasive Parenteral Screening Instruments Market Size, Estimates and Forecasts 2.1.1 Global Non-invasive Parenteral Screening Instruments Revenue 2016-2027 2.1.2 Global Non-invasive Parenteral Screening Instruments Sales 2016-2027 2.2 Global Non-invasive Parenteral Screening Instruments, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Non-invasive Parenteral Screening Instruments Historical Market Size by Region (2016-2021) 2.3.1 Global Non-invasive Parenteral Screening Instruments Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Non-invasive Parenteral Screening Instruments Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Non-invasive Parenteral Screening Instruments Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Region (2022-2027) 2.4.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Region (2022-2027) 3 Global Non-invasive Parenteral Screening Instruments Competitor Landscape by Players 3.1 Global Top Non-invasive Parenteral Screening Instruments Manufacturers by Sales 3.1.1 Global Non-invasive Parenteral Screening Instruments Sales by Manufacturer (2016-2021) 3.1.2 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Non-invasive Parenteral Screening Instruments Manufacturers by Revenue 3.2.1 Key Non-invasive Parenteral Screening Instruments Manufacturers Covered: Ranking by Revenue 3.2.2 Global Non-invasive Parenteral Screening Instruments Revenue by Manufacturers (2016-2021) 3.2.3 Global Non-invasive Parenteral Screening Instruments Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Non-invasive Parenteral Screening Instruments Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Instruments Revenue in 2020 3.2.6 Global Non-invasive Parenteral Screening Instruments Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Non-invasive Parenteral Screening Instruments Price by Manufacturers 3.4 Global Non-invasive Parenteral Screening Instruments Manufacturing Base Distribution, Product Types 3.4.1 Non-invasive Parenteral Screening Instruments Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Non-invasive Parenteral Screening Instruments Product Type 3.4.3 Date of International Manufacturers Enter into Non-invasive Parenteral Screening Instruments Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Non-invasive Parenteral Screening Instruments Market Size by Type (2016-2021) 4.1.1 Global Non-invasive Parenteral Screening Instruments Sales by Type (2016-2021) 4.1.2 Global Non-invasive Parenteral Screening Instruments Revenue by Type (2016-2021) 4.1.3 Non-invasive Parenteral Screening Instruments Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Type (2022-2027) 4.2.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Type (2022-2027) 4.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Type (2022-2027) 4.2.3 Non-invasive Parenteral Screening Instruments Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Non-invasive Parenteral Screening Instruments Market Size by Application (2016-2021) 5.1.1 Global Non-invasive Parenteral Screening Instruments Sales by Application (2016-2021) 5.1.2 Global Non-invasive Parenteral Screening Instruments Revenue by Application (2016-2021) 5.1.3 Non-invasive Parenteral Screening Instruments Price by Application (2016-2021) 5.2 Non-invasive Parenteral Screening Instruments Market Size Forecast by Application (2022-2027) 5.2.1 Global Non-invasive Parenteral Screening Instruments Sales Forecast by Application (2022-2027) 5.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Application (2022-2027) 5.2.3 Global Non-invasive Parenteral Screening Instruments Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 6.1.1 United States Non-invasive Parenteral Screening Instruments Sales YoY Growth 2016-2027 6.1.2 United States Non-invasive Parenteral Screening Instruments Revenue YoY Growth 2016-2027 6.1.3 United States Non-invasive Parenteral Screening Instruments Market Share in Global Market 2016-2027 6.2 United States Non-invasive Parenteral Screening Instruments Market Size by Players (International and Local Players) 6.2.1 United States Top Non-invasive Parenteral Screening Instruments Players by Sales (2016-2021) 6.2.2 United States Top Non-invasive Parenteral Screening Instruments Players by Revenue (2016-2021) 6.3 United States Non-invasive Parenteral Screening Instruments Historic Market Review by Type (2016-2021) 6.3.1 United States Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2016-2021) 6.3.2 United States Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2016-2021) 6.3.3 United States Non-invasive Parenteral Screening Instruments Price by Type (2016-2021) 6.4 United States Non-invasive Parenteral Screening Instruments Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Non-invasive Parenteral Screening Instruments Sales Forecast by Type (2022-2027) 6.4.2 United States Non-invasive Parenteral Screening Instruments Revenue Forecast by Type (2022-2027) 6.4.3 United States Non-invasive Parenteral Screening Instruments Price Forecast by Type (2022-2027) 6.5 United States Non-invasive Parenteral Screening Instruments Historic Market Review by Application (2016-2021) 6.5.1 United States Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2016-2021) 6.5.2 United States Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2016-2021) 6.5.3 United States Non-invasive Parenteral Screening Instruments Price by Application (2016-2021) 6.6 United States Non-invasive Parenteral Screening Instruments Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Non-invasive Parenteral Screening Instruments Sales Forecast by Application (2022-2027) 6.6.2 United States Non-invasive Parenteral Screening Instruments Revenue Forecast by Application (2022-2027) 6.6.3 United States Non-invasive Parenteral Screening Instruments Price Forecast by Application (2022-2027) 7 North America 7.1 North America Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 7.2 North America Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country 7.2.1 North America Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021) 7.2.2 North America Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 8.2 Asia Pacific Non-invasive Parenteral Screening Instruments Market Facts & Figures by Region 8.2.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region (2016-2021) 8.2.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 9.2 Europe Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country 9.2.1 Europe Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021) 9.2.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 10.2 Latin America Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country 10.2.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021) 10.2.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Facts & Figures by Country 11.2.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2016-2021) 11.2.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 GE Healthcare 12.1.1 GE Healthcare Corporation Information 12.1.2 GE Healthcare Description and Business Overview 12.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GE Healthcare Non-invasive Parenteral Screening Instruments Products Offered 12.1.5 GE Healthcare Recent Development 12.2 Philips 12.2.1 Philips Corporation Information 12.2.2 Philips Description and Business Overview 12.2.3 Philips Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Philips Non-invasive Parenteral Screening Instruments Products Offered 12.2.5 Philips Recent Development 12.3 Illumina 12.3.1 Illumina Corporation Information 12.3.2 Illumina Description and Business Overview 12.3.3 Illumina Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Illumina Non-invasive Parenteral Screening Instruments Products Offered 12.3.5 Illumina Recent Development 12.4 Thermo Fisher Scientific 12.4.1 Thermo Fisher Scientific Corporation Information 12.4.2 Thermo Fisher Scientific Description and Business Overview 12.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Products Offered 12.4.5 Thermo Fisher Scientific Recent Development 12.5 Roche 12.5.1 Roche Corporation Information 12.5.2 Roche Description and Business Overview 12.5.3 Roche Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Roche Non-invasive Parenteral Screening Instruments Products Offered 12.5.5 Roche Recent Development 12.6 PacBio 12.6.1 PacBio Corporation Information 12.6.2 PacBio Description and Business Overview 12.6.3 PacBio Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.6.4 PacBio Non-invasive Parenteral Screening Instruments Products Offered 12.6.5 PacBio Recent Development 12.7 Perkinelmer 12.7.1 Perkinelmer Corporation Information 12.7.2 Perkinelmer Description and Business Overview 12.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Perkinelmer Non-invasive Parenteral Screening Instruments Products Offered 12.7.5 Perkinelmer Recent Development 12.8 Qiagen 12.8.1 Qiagen Corporation Information 12.8.2 Qiagen Description and Business Overview 12.8.3 Qiagen Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Qiagen Non-invasive Parenteral Screening Instruments Products Offered 12.8.5 Qiagen Recent Development 12.9 Agilent Technologies 12.9.1 Agilent Technologies Corporation Information 12.9.2 Agilent Technologies Description and Business Overview 12.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Agilent Technologies Non-invasive Parenteral Screening Instruments Products Offered 12.9.5 Agilent Technologies Recent Development 12.10 BGI Group 12.10.1 BGI Group Corporation Information 12.10.2 BGI Group Description and Business Overview 12.10.3 BGI Group Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.10.4 BGI Group Non-invasive Parenteral Screening Instruments Products Offered 12.10.5 BGI Group Recent Development 12.11 GE Healthcare 12.11.1 GE Healthcare Corporation Information 12.11.2 GE Healthcare Description and Business Overview 12.11.3 GE Healthcare Non-invasive Parenteral Screening Instruments Sales, Revenue and Gross Margin (2016-2021) 12.11.4 GE Healthcare Non-invasive Parenteral Screening Instruments Products Offered 12.11.5 GE Healthcare Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Non-invasive Parenteral Screening Instruments Industry Trends 13.2 Non-invasive Parenteral Screening Instruments Market Drivers 13.3 Non-invasive Parenteral Screening Instruments Market Challenges 13.4 Non-invasive Parenteral Screening Instruments Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Non-invasive Parenteral Screening Instruments Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（耐久財）の最新刊レポート
QYResearch社の耐久財分野での最新刊レポート
本レポートと同じKEY WORD（instruments）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
